CSBR Earnings Date: Dec 15, 2026 (Estimated) — Champions Oncology, Inc.
NASDAQ · Healthcare · Biotechnology
Updated
When is CSBR's next earnings date?
Champions Oncology, Inc. (CSBR) is expected to report Q2 2027 earnings on Tuesday, December 15, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of $0.02 on revenue of $16.4M.
How did CSBR do in its last earnings report?
In its most recent report on Sep 10, 2026 (Q1 2027), Champions Oncology, Inc. posted EPS of $0.05 versus the -$0.01 estimate, a beat of 600.0%. Revenue was $15.2M against a $15.0M estimate. The stock's 1-day post-earnings move was +0.1%.
How much does CSBR stock move after earnings?
CSBR beat EPS estimates in 7 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 9.3% (up or down) in the day after earnings.
About Champions Oncology, Inc.
Champions Oncology, Inc. is dedicated to developing and commercializing cutting-edge technological products and services designed to personalize cancer treatment and streamline the development of oncology drugs across the United States. At the heart of its offerings is the Tumorgraft Technology Platform, an innovative approach that facilitates individualized cancer care by implanting human tumors into immune-deficient mice. Utilizing this proprietary platform, the company not only delivers personalized cancer solutions directly but also provides Translational Oncology Solutions, supporting pharmaceutical and biotechnology companies through their drug development lifecycle. Additionally, Champions Oncology offers Lumin Bioinformatics, a comprehensive software platform and data tool filled with insights from research services and clinical studies, accessible through annual subscriptions. The company distributes its offerings through various channels, including online platforms, word-of-mouth referrals, and a dedicated sales team, reaching both patients and healthcare professionals. Established in 1985, Champions Oncology, Inc. is based in Hackensack, New Jersey, and was formerly known as Champions Biotechnology, Inc. until its name change in April 2011.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-10 | Q1 2027 | -0.01 | 0.05 | +600.00% | $15.2M | ✅ Beat | +0.09% | -0.30% | -5.01% |
| 2026-07-27 | Q4 2026 | -0.05 | 0.01 | +120.00% | $13.8M | ✅ Beat | -8.75% | -4.95% | -17.82% |
| 2026-03-12 | Q3 2026 | 0.09 | 0.04 | -55.56% | $16.6M | ❌ Miss | +6.27% | +8.01% | +0.00% |
| 2025-12-15 | Q2 2026 | 0.01 | 0.06 | +500.00% | $15.0M | ✅ Beat | -13.72% | -7.05% | -8.04% |
| 2025-09-15 | Q1 2026 | -0.01 | 0.02 | +300.00% | $14.0M | ✅ Beat | +21.52% | -3.88% | -4.69% |
| 2025-03-11 | Q3 2025 | 0.30 | 0.36 | +20.00% | $17.0M | ✅ Beat | -2.45% | -1.84% | -13.59% |
| 2024-12-11 | Q2 2025 | 0.01 | 0.05 | +400.00% | $13.5M | ✅ Beat | -11.64% | +18.32% | +65.58% |
| 2024-09-11 | Q1 2025 | -0.03 | 0.11 | +466.67% | $14.1M | ✅ Beat | +9.58% | +5.16% | +15.23% |
Showing last 8 quarters.